1. DOP70 Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective study. (21st January 2022) Authors: Mahmoud, R; Savelkoul, E; Mares, W; Goetgebuer, R; Witteman, B; de Koning, D; Minderhoud, I; van Tuyl, S; van Boeckel, P; Mahmmod, N; Lutgens, M; Horjus, C; Römkens, T; Akol-Simsek, D; Jansen, J; Hoentjen, F; Jharap, B; Oldenburg, B Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗